New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth and neovascularization (Q73592166)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth and neovascularization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

(2R,4aS,6aS,12bR,14aS,14bR)-9-formyl-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

5 November 2019

main subject

Tripterygium wilfordii

1 reference

inferred from

reverse claim

1 reference

S Ushiro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Ono

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Nakayama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Fujiwara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y Komatsu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Sugimachi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Kuwano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

657-663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis

5 November 2019

cites work

0 references

Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis

0 references

Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro

0 references

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

0 references

Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells

0 references

D:A-friedo-24-noroleanane triterpenoids from Tripterigium wilfordii

0 references

Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells

0 references

Vincristine-resistant human cancer KB cell line and increased expression of multidrug-resistance gene

0 references

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

0 references

Vascular occlusion and tumour cell death

0 references

Molecular foundations of cancer: new targets for intervention

0 references

Irsogladine is a potent inhibitor of angiogenesis

0 references

Responses of B16 melanoma cell lines, F1 and F10, to hyperthermia, lymphokine-activated killer cells and a combination of both in vitro

0 references

Angiogenesis in cancer, vascular, rheumatoid and other disease

0 references

Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.

0 references

Genistein, a dietary-derived inhibitor of in vitro angiogenesis

0 references

Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro

0 references

Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells.

0 references

Thalidomide is an inhibitor of angiogenesis

0 references

Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis

0 references

Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator

0 references

Impaired wound healing in mice with a disrupted plasminogen gene

0 references

Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2

0 references

Identifiers

DOI

10.1002/(SICI)1097-0215(19970807)72:4<657::AID-IJC18>3.0.CO;2-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9259407%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference